Active Surveillance Patients International

ASPI is a patient-run international organization founded by men with prostate cancer (PCa) to support newly diagnosed men with low & intermediate grade PCa.

[Active Surveillance Patients International @ASPI_INTL]

What happens when doctors become patients?

Our latest ASPI webinar replay is now available, featuring physicians with personal experience of prostate cancer sharing lessons from the patient side of care.

Watch here:
https://t.co/Iiu9Q1sZiH
#ProstateCancer #ActiveSurveillance

[Active Surveillance Patients International @ASPI_INTL]

We’re pleased to share the video of last month’s session featuring Dr. John Oliffe of UBC. In our March webinar, he explored anxiety, uncertainty, and support for men living with prostate cancer on Active Surveillance. Watch and learn more here: https://t.co/h4bz0PCvYa

[Active Surveillance Patients International @ASPI_INTL]

Doctors get prostate cancer too.

What happens when the expert becomes the patient?

Join our April 25 ASPI session to hear physicians share their experiences—from Active Surveillance to treatment and beyond.

🗓 Apr 25 | 12 PM ET
🔗 https://t.co/qYE2IeFYGY

[Active Surveillance Patients International @ASPI_INTL]

Replay now available: Prostate Biopsy: The Beginning of the End? with Prof. Mark Emberton (UCL).

How prostate MRI (and sometimes PSMA PET) is changing biopsy decisions—reducing unnecessary biopsies while still identifying clinically significant cancers.

Watch: https://t.co/3y6rMlFR3t
#ProstateCancer #ActiveSurveillance #ProstateMRI #PSMAPET

[Active Surveillance Patients International @ASPI_INTL]

Active Surveillance anxiety is real—and it doesn’t always disappear after treatment.

Join us for our monthly webinar on Mar 28, 2026 @ 12 PM ET:
'A prostatectomy doesn’t cure anxiety' with Dr. John Oliffe (UBC) + live Q&A.

Register now: https://t.co/RlNhHurQWP
#ActiveSurveillance #ProstateCancer

[Active Surveillance Patients International @ASPI_INTL]

Clinical trials can offer access to promising approaches, more structured follow-up, and experienced research teams.

ASPI’s brand new Active Surveillance Clinical Trial Finder Tool helps you find AS-relevant trials in just a couple of clicks. Check it out at:
https://t.co/K98hjlJ48f

#ActiveSurveillance #ProstateCancer #ClinicalTrials

[Active Surveillance Patients International @ASPI_INTL]

Prostate Biopsy – The Beginning of the End?
How MRI is changing prostate biopsy decisions and helping many men avoid unnecessary procedures.

Join ASPI’s live webinar with Dr. Mark Emberton, global imaging leader.
Sat Feb 28 | 12 PM ET
Live Q&A
👉Register: https://t.co/0L0rIV632B

[Active Surveillance Patients International @ASPI_INTL]

📣January 2026 ASPI Report:
What the latest research suggests about weight, movement, and metabolic health for men on Active Surveillance.

🔗 Check it out: https://t.co/zdET3QX7zL

#ActiveSurveillance #ProstateCancer

[Active Surveillance Patients International @ASPI_INTL]

📣Time update + last chance to register!

Our ASPI webinar with Dr. Jonathan Epstein—one of the most influential prostate cancer pathologists globally—now starts at 10:00 AM ET this Saturday (Jan 24).

Learn what prostate biopsy reports show, miss, or get wrong. Live Q&A included.

Register now: https://t.co/xwYlh9fJHx

(A recording will be made available on https://t.co/e2vNxzWXil within a week of the meeting.)

[Jim Hu @jimhumd]

Thanks @ASPatientsIntl @ASPI_INTL for the merch!

[Active Surveillance Patients International @ASPI_INTL]

Nutrition won’t replace Active Surveillance — but research shows it may support inflammation, metabolism, and quality of life.

Our December ASPI Report reviews key diet studies for men on AS, with practical guidance for the holidays.

Check it out at: https://t.co/2FemRdJX7Z

[Active Surveillance Patients International @ASPI_INTL]

Your Giving Tuesday support helps men stay confident, informed, and in control after a prostate cancer diagnosis.

With over $13,000 raised — and lean admin costs — your gift goes directly into patient-friendly education and outreach.

Thank you. ✨ https://t.co/nMs5esDc0P

[Active Surveillance Patients International @ASPI_INTL]

Incredible speakers on the latest research in prostate biopsies - thank you so much for your support, @jimhumd, @BadarMian1 and @lambalistair!

Video of their discussion on transrectal vs. transperineal biopsy is now available: https://t.co/B9FrAJ5rOh

[Jim Hu @jimhumd]

delighted to participate with @BadarMian1 @LambAlastair on a Saturday discussion about Transperineal vs Transrectal prostate biopsy with @ASPatientsIntl @ASPI_INTL

[Active Surveillance Patients International @ASPI_INTL]

Our latest ASPI roundtable breaks down what new trials show about transperineal vs. transrectal biopsies — safety, detection, antibiotics, and comfort.

Watch here 👉 https://t.co/B9FrAJ4TYJ

Note: No December meeting — see you again in January!

[Active Surveillance Patients International @ASPI_INTL]

Check out our November newsletter, The ASPI Report: A Clearer Picture on Grading. We go over the latest research in grading — how prostate cancer's aggressiveness is measured — and what that really means for Active Surveillance patients. - https://t.co/vs6qqvJpHy

[Active Surveillance Patients International @ASPI_INTL]

Major trials are reshaping prostate biopsy—a potential game changer for #ActiveSurveillance.
Transrectal vs transperineal—which is safer and more accurate?
Hear Drs. Hu, Lamb & Mian at ASPI’s free roundtable, Nov 22 (12–1:30 PM ET).
Register 👉: https://t.co/1Usex15e3R

[Active Surveillance Patients International @ASPI_INTL]

🎁 No tricks — just triple impact!
From Nov 1–Dec 2, all gifts to ASPI are matched, and IRA (QCD) gifts are double matched (tripling your impact, up to $5K).
Help men live well on Active Surveillance.
🔗 https://t.co/UFSiOkdRqA